Leading by example

Board of Directors

Chairman & Managing Director
Glenn Saldanha
+
Chairman & Managing DirectorGlenn Saldanha

Mr. Glenn Saldanha is the Chairman & Managing Director of Glenmark Pharmaceuticals Ltd. He joined in 1998 as Director and took over as Managing Director & CEO in 2001.

As Chairman & Managing Director of the Company, Mr. Saldanha oversees all operations of the organization. During his tenure, he has transformed Glenmark into a truly global organization with revenues of over a billion dollars and a commercial presence in over 80 countries. Under his leadership, Glenmark has evolved from an Indian branded generics business into a research-driven and innovation-led organization. Mr. Saldanha’s vision for Glenmark is to discover, develop and take to market India's first innovative drug.

Mr. Saldanha holds a Bachelor's Degree in Pharmacy from Mumbai University and is an MBA from the Leonard Stern School of Business at New York University. Prior to Glenmark, he worked with Eli Lily, USA and PricewaterhouseCoopers, USA.

Executive Director – Corporate Affairs
Cherylann Pinto
+
Executive Director – Corporate AffairsCherylann Pinto

Ms. Cherylann Pinto is an executive member of the Board of Directors and is one of the promoters of Glenmark Pharmaceuticals Ltd. She has over 28 years of experience in the pharma industry and has been associated with Glenmark since 1999. As Director - Corporate Affairs, she heads Glenmark’s Human Resource (HR), Information Technology (IT), Administration, Corporate Communications, Corporate Social Responsibility (CSR) and Corporate Affairs functions. Prior to her association with Glenmark, Ms. Pinto founded a pharmaceutical company and was its Managing Director for 10 years.

Under her leadership, Glenmark’s CSR initiatives won the prestigious Bombay Chambers of Commerce Award 2014 for their contribution to child health, reducing malnutrition and infant mortality, improving access to medicines and providing sustainable livelihoods. Ms. Pinto has received the ‘Women Leadership Award’ at the CMO Asia’s 5th Best CSR Practices Award function in 2015. She has been acknowledged as one of the 100 Most Impactful CSR Leaders globally by the World CSR Congress in 2017.

Ms.Pinto holds a Bachelor's Degree in Pharmacy from the Institute of Chemical Technology in Mumbai and has also completed the General Management Program from the Harvard Business School in Boston.

Executive Director & Global General Counsel
Murali Neelakantan
+
Executive Director & Global General CounselMurali Neelakantan

Mr. Murali Neelakantan is Global General Counsel at Glenmark Pharmaceuticals Ltd. He leads Glenmark's Legal and Compliance functions globally. Mr. Neelakantan has more than two decades of international experience advising companies in a wide variety of sectors ranging from utilities to financial services.

He has held leadership positions at international law firms such as Arnold & Porter and Ashurst LLP, and at leading Indian law firm, Khaitan & Co. He was also the Global General Counsel at pharmaceutical company Cipla.

Mr. Neelakantan graduated with honours from National Law School of India University and is qualified to practice law in India, England and Wales.

Non-Executive Director
Rajesh V Desai
+
Non-Executive DirectorRajesh V Desai

Mr. Rajesh V. Desai is a Non-Executive Director at Glenmark Pharmaceuticals Ltd. Mr. Desai has over 34 years of work experience. He was the Chief Financial Officer of Glenmark until 2016. He led the Finance, Legal & IT functions and, with a strong background in finance, contributed significantly to the growth story of Glenmark.

Mr. Desai holds a Bachelor's Degree in Science from the Bombay University and is a Chartered Accountant from the Institute of Chartered Accountants of India.

Non-Executive Director
Brian W Tempest
+
Non-Executive DirectorBrian W Tempest

Dr. Brian W. Tempest is the Editor of the Journal of Generic Medicines. He is also a Non-Executive Director on the Governance Board of the United Nations Patent Pool. Previously he worked for Ranbaxy Laboratories since 1995 holding the position of Managing Director and Chief Executive Officer until 2005. He was then Chief Mentor and Non-Executive Director until 2008.

Dr. Tempest has also worked for Glaxo as Regional Director Far East and Regional Director Middle East & Africa from 1985 to 1992. He has worked in the Pharmaceutical Industry for the last 45 years and has managed Healthcare businesses in North America, South America, Europe, Africa, Middle East, Australasia, China, Japan and India.

Dr. Tempest is now a Non-Executive Director of Religare Capital Markets, Fortis Healthcare, SRL Diagnostics and Petainer-Innopac. He is a member of the SCRIP Global awards panel. He is also an international advisor to UNCTAD and MAPE, an Indian M&A boutique. Dr. Tempest has a PhD in Polymer Chemistry from Lancaster University and a D.Sc. (Hon) from Aston University, UK. In 2009 he became Chairman of the Advisory Board for the Lancaster University Management School, UK. He is a Fellow of the Royal Society of Medicine, a Fellow of the Royal Society of Chemistry and is a Chartered Chemist.

Non-Executive Director
Bernard Munos
+
Non-Executive DirectorBernard Munos

Mr.Bernard Munos is a Senior Fellow at FasterCures, a center of the Milken Institute. His research on pharmaceutical innovation has been published in Nature and Science, as also profiled by Forbes magazine. The popular industry newsletter FiercePharma has named him one of the 25 most influential people in biopharma.

Mr. Munos advises organizations on being better innovators. He serves on the Advisory Council of the National Center for Advancing Translational Sciences (NCATS); is a member of the National Academy of Medicine's Forum on Drug R&D and Translation; an Advisor to the journal Science Translational Medicine; and an Advisor to or Board member of multiple companies and publicly-financed research organizations.

Mr. Munos has discussed his research at numerous meetings sponsored by the President's Cancer Panel, the NIH Leadership Forum, the FDA, the World Health Organization, the OECD, the New York Academy of Sciences, the Brookings Institution, the Kauffman Foundation, the US Patent and Trademark Office, the American Chemical Society, as well as leading universities in the US, Europe, and Asia. He also blogs on innovation for Forbes and FastCures.

Mr. Munos received his MBA from Stanford University, and holds other graduate Degrees from the University of California at Davis, and the Paris Institute of Technology for Life, Food and Environmental Sciences in France.

Non-Executive Director
Blanche E. Saldanha
+
Non-Executive DirectorBlanche E. Saldanha

Mrs. Blanche E. Saldanha is a Non-Executive Director and a member of the promoter group of Glenmark Pharmaceuticals Limited. Prior to this position, Mrs. Saldanha was the Director – Exports and managed Glenmark’s international operations from 1982 to 2005. During her 23-year tenure with the organization, she was responsible for developing and growing the company’s export business.

Mrs. Saldanha holds a Bachelor's Degree in Science and a Bachelor's Degree in Education from Bombay University.

Non-Executive Director
Julio Ribeiro
+
Non-Executive DirectorJulio Ribeiro

Mr. Julio Ribeiro has been associated with Glenmark since 1999. He is a retired Indian police officer and civil servant with a long and illustrious career. Some of the noteworthy positions that he has held are: the Commissioner of Police, Mumbai; Special Secretary to the Government of India, Ministry of Home Affairs; Director General of Police, Punjab; Adviser to the Governor of Punjab and Ambassador of India to Romania.

Mr. Ribeiro was conferred with the Padma Bhushan, India's third-highest civilian award for his services in 1987. He served as an Independent Director of Fullerton India Credit Company Limited until 2011 and currently serves as Director of VVF Ltd. Mr. Ribeiro holds a Bachelor's Degree in Commerce and a Bachelor's Degree in Law from the Bombay University.

Non-Executive Director
Sridhar Gorthi
+
Non-Executive DirectorSridhar Gorthi

Mr. Sridhar Gorthi is Partner in the Mumbai office of Trilegal and his areas of expertise include mergers and acquisitions (M&A), joint ventures, private equity and venture capital. He has been actively involved in several high-profile, cross-border transactions and is a leading member of Trilegal's corporate practice. Apart from representing a number of international clients for M&A in India, Mr. Gorthi has also advised Indian companies in connection with outbound M&A transactions in the UK, USA, South Africa, Argentina, Indonesia and Sri Lanka.

Mr. Gorthi has been named one of the leading lawyers for Mergers & Acquisitions, Private Equity and Venture Capital in India by the Guide to Asia Pacific’s Leading Lawyers 2010, 2011 and 2012; and by IFLR 1000 in 2011 and 2012.

Non-Executive Director
Milind Sarwate
+
Non-Executive DirectorMilind Sarwate

Mr. Milind Sarwate is the Founder and CEO of Increate Value Advisors LLP, a firm that facilitates organizations and individuals to discover, develop and deliver business and social value. He has over 32 years of experience in Finance, HR and Strategy in groups such as Marico and Godrej.

Mr. Sarwate has received the ICAI Award - CFO - FMCG 2011, CNBC TV-18 Best Performing CFO Award - FMCG & Retail - 2012 and was also included in the CFO India Hall of Fame 2013 by CFO India magazine.

He is a Chartered Accountant, Cost Accountant and Company Secretary, and holds a Bachelor's Degree in Commerce from the Bombay University. He is a CII-Fulbright Fellow (Carnegie Mellon University, Pittsburgh, PA, USA).

Non-Executive Director
D. R. Mehta
+
Non-Executive DirectorD. R. Mehta

Mr. D.R. Mehta joined the Indian Administrative Service in 1961 and held numerous important positions initially in the Government of Rajasthan and later in the Government of India. He has served as Chairman of the Securities and Exchange Board of India, the Deputy Governor of the Reserve Bank of India, and the Director General of Foreign Trade, Ministry of Commerce and Government of India. He was also the Controller of Capital Issues, and Additional Secretary, Banking in the Ministry of Finance in the Government of India.

Mr. Mehta is the founder and chief patron of Bhagwan Mahaveer Viklang Sahayata Samiti (BMVSS) Jaipur, the world's largest organization for the rehabilitation of the handicapped. He was conferred with the Padma Bhushan in 2008 and the Rajiv Gandhi National Sadbhavana Award in 2012. Mr. Mehta holds a Bachelor's Degree in Arts and an LLB Degree from the Rajasthan University. He also holds Management Degrees from the Royal Institute of Public Administration, London and the Alfred Sloan School of Management, MIT, Boston, US.

Founder Emeritus

Late Mr. Gracias Saldanha

"Glenmark has been built on the pillars of Integrity, Knowledge, Trust & Respect"